BRF2 knockdown can inhibit the migratory and invasive abilities of non-small cell lung cancer cells (NSCLCs) and induce the loss of the epithelial-mesenchymal transition [7,9,10]. The gene discussed is BRF2; the disease is non-small cell lung carcinoma.